TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AFT Stock 12 Month Forecast
Average Price Target
―
Based on 1 Wall Street analysts offering 12 month price targets for AFT Pharmaceuticals Ltd. in the last 3 months. The average price target is ― with a high forecast of ― and a low forecast of ―. The average price target represents a ― change from the last price of ―.
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +15.30% per trade.
Copying Adrian Allbon's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +15.30% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +15.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AFT Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
1
1
In the current month, AFT has received 1Buy Ratings, 0Hold Ratings, and 0Sell Ratings. AFT average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
AFT Financial Forecast
AFT Earnings Forecast
The previous quarter’s earnings for AFT were $0.03.
The previous quarter’s earnings for AFT were $0.03.
AFT Sales Forecast
Next quarter’s sales forecast for AFT is $146.80M with a range of $146.80M to $146.80M. The previous quarter’s sales results were $114.94M. AFT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AFT has Performed in-line its overall industry.
Next quarter’s sales forecast for AFT is $146.80M with a range of $146.80M to $146.80M. The previous quarter’s sales results were $114.94M. AFT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AFT has Performed in-line its overall industry.
AFT Stock Forecast FAQ
What is NZ:AFT’s average 12-month price target, according to analysts?
Currently, no data Available
What is NZ:AFT’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for NZ:AFT, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AFT Pharmaceuticals Ltd. a Buy, Sell or Hold?
AFT Pharmaceuticals Ltd. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is AFT Pharmaceuticals Ltd.’s share price target?
Currently, no data Available
What do analysts say about AFT Pharmaceuticals Ltd.?
AFT Pharmaceuticals Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of AFT Pharmaceuticals Ltd.?
To buy shares of NZ:AFT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.